Anti-Obesity Effect of Pediococcus Pentosaceus LP28

A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Effect of Pediococcus Pentosaceus LP28 on Obesity

This study is designed to evaluate efficacy of Pediococcus pentosaceus LP28 in reducing body fat and body weight in subjects with BMI 25-30 kg/m2.

Inclusion Criteria:

• BMI 25-30 kg/m2

Exclusion Criteria:

• Taking medicines or functional food that may affect body weight or body fat
• Pregnant or nursing a child
• Participation in any clinical trial within 90 days of the commencement of the trial
• Renal or hepatic dysfunction
• Heart disease